Abstract
Azo dyes form substantial industrial pollutants owing to their poor biodegradation capacity. Present study identifies azo dye detoxifying strain of bacteria from waste water near textile industries. In order to identify the azo dye degrading strain, 16S rRNA gene was sequenced from the pure bacterial culture obtained from the samples collected from textile industry area at Erode in Tamil Nadu state of India. Two novel azo dye degrading bacteria were found out of 60 samples investigated, which were respectively named Sphingomonas sp strain EMBS022 and Sphingomonas sp strain EMBS023. Isolates of Sphingomonas sp strains - EMBS022 and EMBS023 were deposited in GenBank with accession numbers ‘KF951596’ & ‘KF951597’respectively. UNAFOLD and RNA fold web servers were employed to predict the secondary structure of 16s RNA of these strains. Free energy estimate for secondary structures of 16s rRNA of strains EMBS022 and EMBS023 were ΔG = -159.00 kcal/mol and ΔG = -159.90 kcal/mol, confirming the structures to be considerably stable.
Keywords: Azo dyes degrading bacteria, Sphingomonas species, Sphingomonas sp strain EMBS022 and EMBS023, 16S rRNA gene sequencing.
Current Bioinformatics
Title:Identification of Azo Dye Degrading Sphingomonas Strain EMBS022 and EMBS023 Using 16S rRNA Gene Sequencing
Volume: 10 Issue: 5
Author(s): Anuroopa G. Nadh, Uday Raj Akare, Priya Sharma, Pratibha Yadav, Srinivas Bandaru, Anuraj Nayarisseri and Achuthsankar S. Nair
Affiliation:
Keywords: Azo dyes degrading bacteria, Sphingomonas species, Sphingomonas sp strain EMBS022 and EMBS023, 16S rRNA gene sequencing.
Abstract: Azo dyes form substantial industrial pollutants owing to their poor biodegradation capacity. Present study identifies azo dye detoxifying strain of bacteria from waste water near textile industries. In order to identify the azo dye degrading strain, 16S rRNA gene was sequenced from the pure bacterial culture obtained from the samples collected from textile industry area at Erode in Tamil Nadu state of India. Two novel azo dye degrading bacteria were found out of 60 samples investigated, which were respectively named Sphingomonas sp strain EMBS022 and Sphingomonas sp strain EMBS023. Isolates of Sphingomonas sp strains - EMBS022 and EMBS023 were deposited in GenBank with accession numbers ‘KF951596’ & ‘KF951597’respectively. UNAFOLD and RNA fold web servers were employed to predict the secondary structure of 16s RNA of these strains. Free energy estimate for secondary structures of 16s rRNA of strains EMBS022 and EMBS023 were ΔG = -159.00 kcal/mol and ΔG = -159.90 kcal/mol, confirming the structures to be considerably stable.
Export Options
About this article
Cite this article as:
G. Nadh Anuroopa, Raj Akare Uday, Sharma Priya, Yadav Pratibha, Bandaru Srinivas, Nayarisseri Anuraj and S. Nair Achuthsankar, Identification of Azo Dye Degrading Sphingomonas Strain EMBS022 and EMBS023 Using 16S rRNA Gene Sequencing, Current Bioinformatics 2015; 10 (5) . https://dx.doi.org/10.2174/1574893610666151008012312
DOI https://dx.doi.org/10.2174/1574893610666151008012312 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Base Excision Repair: Contribution to Tumorigenesis and Target in Anticancer Treatment Paradigms
Current Medicinal Chemistry Molecular Chaperone Hsp90 as a Target for Oxidant-Based Anticancer Therapies
Current Medicinal Chemistry Hepatitis C Viruss Immune Evasion Strategies
Current Immunology Reviews (Discontinued) Reactive Oxygen Species: Physiological Roles in the Regulation of Vascular Cells
Current Molecular Medicine Assessing Drug Transport Across the Human Placental Barrier: From In Vivo and In Vitro Measurements to the Ex Vivo Perfusion Method and In silico Techniques
Current Pharmaceutical Biotechnology Consequences of Elevated Homocysteine During Embryonic Development and Possible Modes of Action
Current Pharmaceutical Design Triple-negative Breast Cancer and Poly(ADP-ribose) Polymerase Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Stressed to Death: Targeting Endoplasmic Reticulum Stress Response Induced Apoptosis in Gliomas
Current Pharmaceutical Design CYP2A5 Induction and Hepatocellular Stress: An Adaptive Response to Perturbations of Heme Homeostasis
Current Drug Metabolism CXCR4 and Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry How Do Microtubule-Targeted Drugs Work? An Overview
Current Cancer Drug Targets Advanced Neoplastic Disease as Immunologic, Endocrine and Metabolic Disorder
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Role of NF-κB and NF-κB-regulated Gene Products in Chemoresistance and Radioresistance
Current Cancer Therapy Reviews Molecular Interplay between Platelets and the Vascular Wall in Thrombosis and Hemostasis
Current Vascular Pharmacology Probiotics as a Tool to Biosynthesize Metallic Nanoparticles: Research Reports and Patents Survey
Recent Patents on Drug Delivery & Formulation Chemotherapy Resistance in Breast Cancer
Current Cancer Therapy Reviews Therapeutical Relevance of MAP-Kinase Inhibitors in Renal Diseases: Current Knowledge and Future Clinical Perspectives
Current Medicinal Chemistry Drug-induced Cardiac Mitochondrial Toxicity and Protection: From Doxorubicin to Carvedilol
Current Pharmaceutical Design Synthetic Retinoids and Their Nuclear Receptors
Current Medicinal Chemistry - Anti-Cancer Agents The Use of Metabolising Systems for In Vitro Testing of Endocrine Disruptors
Current Drug Metabolism